Preferred Label : selective estrogen receptor modulators;
MeSH definition : A structurally diverse group of compounds distinguished from ESTROGENS by their ability
to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist
depending on the tissue type and hormonal milieu. They are classified as either first
generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM
or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63);
MeSH synonym : serms; selective estrogen receptor modulator; estrogen receptor modulator, selective; estrogen receptor modulators, selective; serm;
MeSH annotation : do not confuse with ESTROGEN RECEPTOR MODULATORS;
Wikipedia link : https://en.wikipedia.org/wiki/Selective estrogen receptor modulator;
Is substance : O;
action pharmacologique : O;
Origin ID : D020845;
UMLS CUI : C0732611;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Indexing information
Ne pas confondre avec
Record concept(s)
See also
Semantic type(s)
Substance(s)
UMLS correspondences (same concept)
A structurally diverse group of compounds distinguished from ESTROGENS by their ability
to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist
depending on the tissue type and hormonal milieu. They are classified as either first
generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM
or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
https://www.cochrane.org/fr/CD011169/MENSTR_modulateurs-selectifs-des-recepteurs-des-oestrogenes-msre-pour-les-femmes-atteintes-dendometriose
2021
France
United Kingdom
review of literature
french abstract
female
disease
selective estrogen receptor modulators
endometriosis, nos
women
endometriosis
biopsy
biopsy, nos
estrogen receptor site
Endometriosis
---
https://pharmacomedicale.org/medicaments/par-specialites/item/modulateurs-selectifs-des-recepteurs-aux-oestrogenes-serm-et-serd
2018
false
true
false
France
Selective Estrogen Receptor Down Regulator
antineoplastic agents
tamoxifen
toremifene
Raloxifene Hydrochloride
Fulvestrant
selective estrogen receptor modulators
selective estrogen receptor modulators
drug monitoring
drug information
selective estrogen receptor modulators
---
https://pharmacomedicale.org/medicaments/par-specialites/item/serm-modulateurs-recepteurs-oestrogenes
2017
false
true
false
France
selective estrogen receptor modulators
selective estrogen receptor modulators
clomiphene
tamoxifen
toremifene
Raloxifene Hydrochloride
drug monitoring
selective estrogen receptor modulators
drug information
selective estrogen receptor modulators
---
Summary Safety Review - Hormone Replacement Therapy (Estrogenic and Progestogenic
Agents) and Selective Estrogen Receptor Modulators (SERMs) - Assessing the Potential
Risk of Ovarian Cancer
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/hormon-fra.php
2016
false
false
false
Canada
French
English
drug evaluation
canada
risk assessment
hormone replacement therapy
selective estrogen receptor modulators
ovary cancer
menopause
osteoporosis, postmenopausal
hot flashes
time
Long-term drug therapy (procedure)
risk
Raloxifene Hydrochloride
bazedoxifene
progesterone congeners
estrogens
progestins
ovarian neoplasms
indoles
---
http://www.cochrane.org/fr/CD005287
http://www.cochrane.org/fr/CD005287/modulateurs-selectifs-des-recepteurs-aux-oestrogenes-serm-pour-les-fibromes-uterins
2012
false
true
false
United Kingdom
France
treatment outcome
selective estrogen receptor modulators
review of literature
french abstract
leiomyoma
selective estrogen receptor modulators
---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/4A/67/resume.phtml?type=text.html
2009
France
French
journal article
selective estrogen receptor modulators
antineoplastic agents, hormonal
breast neoplasms
Raloxifene Hydrochloride
tamoxifen
---
https://minerva-ebp.be/fr/article/695
2006
false
false
minerva-ebm.be
Belgium
French
osteoporosis, postmenopausal
breast neoplasms
bone density conservation agents
estrogen antagonists
selective estrogen receptor modulators
fractures, bone
treatment outcome
Raloxifene Hydrochloride
critical appraisal or critical reading
---
http://www.cbip.be/Folia/index.cfm?FoliaWelk=F33F10C
2006
Belgium
French
primary prevention
breast neoplasms
tamoxifen
Raloxifene Hydrochloride
breast neoplasms
selective estrogen receptor modulators
journal article
---
https://www.cadth.ca/sites/default/files/pdf/117_raloxifene_tr_f.pdf
https://www.cadth.ca/fr/etude-methodique-de-lefficacite-et-de-linnocuite-du-raloxifene-dans-la-prevention-primaire-ou
2005
true
Canada
French
Raloxifene Hydrochloride
osteoporosis, postmenopausal
selective estrogen receptor modulators
fractures, bone
Raloxifene Hydrochloride
selective estrogen receptor modulators
treatment outcome
randomized controlled trials as topic
aged
canada
osteoporosis, postmenopausal
spinal fractures
bone density
osteoporosis, postmenopausal
signs and symptoms
risk factors
bibliography of medicine
incidence
placebos
fractures, bone
prevalence
thromboembolism
hot flashes
breast neoplasms
cardiovascular diseases
morbidity
bone density conservation agents
technical report
evaluation studies
french abstract
meta-analysis
---